Extraordinary Index Adjustment – SUCAMPO PHARMACEUTICALS-CL A

Due to the acquisition of SUCAMPO PHARMACEUTICALS-CL A by MALLINCKRODT PHARMACEUTICALS, the following treatment will be applied to the following indices.

Solactive US Broad Market Index

Solactive US Extended Broad Market Index

Solactive US Small Cap Index

Solactive US Small & Mid Cap Index

  • SUCAMPO PHARMACEUTICALS-CL A will be removed from the Index.
  • The weight of SUCAMPO PHARMACEUTICALS-CL A based on its last close price will be distributed pro rata to remaining Index constituents.
  • Effective Date (open): 02/16/2018.